Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments - Wikidata - awgldk - TriplyDB

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments

http://www.wikidata.org/entity/Q27022866

about

Primary Cutaneous Nocardiosis in a Patient With Nephrotic Syndrome: A Case Report and Review of the Literature Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment What is hidradenitis suppurativa?Qu’est-ce que l’hidradénite suppurée?Eccrine sweat gland development and sweat secretion Bacterial pathogens associated with hidradenitis suppurativa, France.The bacteriology of hidradenitis suppurativa: a systematic review.The intersection of microbiome and host at the skin interface: genomic- and metagenomic-based insights.The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.Epidermal psoriasiform hyperplasia, an unrecognized sign of folliculitis decalvans: A histological study of 26 patients.Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients.Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.MMP8 Is Increased in Lesions and Blood of Acne Inversa Patients: A Potential Link to Skin Destruction and Metabolic Alterations.The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.Bacterial biofilm in chronic lesions of hidradenitis suppurativa.Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report.Hidradenitis Suppurativa and the Association With Hematological Malignancies.Cytokine analysis in hidradenitis suppurativa supports therapeutic approaches.Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.Acne inversa complicated by Actinomyces neuii.Atypical hidradenitis suppurativa.Remission of hidradenitis suppurativa after bariatric surgery.Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials.Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology.A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).Haematoxylin and eosin staining identifies medium to large bacterial aggregates with a reliable specificity: A comparative analysis of follicular bacterial aggregates in axillary biopsies using peptide nucleic acid-fluorescence in situ hybridization Does obesity cause a distinct phenotype of hidradenitis suppurativa?Hidradenitis Suppurativa: Inside and Out.Clinical and histopathological characteristics in patients with scarring folliculitis type of acne inversa.Hidradenitis suppurativa is not associated with the metabolic syndrome based on body type: A cross-sectional study.Mechanical stress and the development of pseudo-comedones and tunnels in Hidradenitis suppurativa/Acne inversa.Hidradenitis Suppurativa in Kuala Lumpur, Malaysia: A 7-Year Retrospective Review.Complement Activation in Inflammatory Skin Diseases.Hidradenitis suppurativa in a patient with hyperandrogenism, insulin-resistance and acanthosis nigricans (HAIR-AN syndrome).

P2860

Q26773442-DC2D8AEB-12A0-4EE9-B0CF-7B1E46FF8F6F Q26828789-E83BE8B8-DF54-4333-BF9F-1EE2FD1FBBF2 Q30234313-1A9DF270-FFAD-40D4-B11E-F795C6A7C5E7 Q30234599-941CFDF1-D08D-49B7-BEBC-6D0FED8A8BCB Q30235909-B2EACE26-59E6-4F8D-89AC-EECFCE78C89E Q33575025-91E57692-52EB-46EA-AB9F-83CB57771814 Q33901945-FEB4719C-E14B-44C8-B517-E41ED114CF47 Q34641244-4F1AEB54-DD32-4513-87C0-65CBB728D501 Q35676683-74A96D48-AF5B-45DD-BAC0-3E92908B5179 Q35796426-EC023A5E-6003-4338-A9E8-D0C0B7CF4352 Q38558963-499E0648-5663-464F-8083-93CF8EA1BF87 Q38716257-A3F19B69-D5A7-491A-81E4-7B099BA001BD Q39032243-06E8392B-52B0-4F6F-8614-A73F3469C5FD Q40384773-62502740-EFBA-43CA-8F4E-FC85A844E202 Q40393434-09AC0D07-6AFD-417A-9082-2D347187C05E Q40452424-99609DE9-C186-46D3-8F94-D53E6FBEF508 Q40520394-B1F56B63-8727-41EB-8D4E-7B35C910AF00 Q40562171-5468DB8C-6050-43D8-8934-6F6B024E535A Q40586896-8394ACFF-8F73-44E3-8305-F64141DBE8AA Q40602785-B586306F-8B27-44DC-BFC0-C10844EDBA5D Q40855752-7122FCD6-F3DD-4395-9A3E-422106A6266D Q40911079-A2451BB6-C098-450D-894B-48273E9EB40D Q41047761-89D2E7DC-1537-49D6-AF18-07AE6935036A Q41100402-18979A54-B587-4D86-8129-F52DAA5C2CEE Q41130379-D030B4D9-44A1-44DE-9FFE-ABD3DDEDEC20 Q41281838-21DE5723-85D4-414F-87A5-6E0C4A985ABD Q41299393-7FAC6CAA-0C2E-4F2D-B03A-1009628F51B8 Q45002156-5E10AE43-38EC-4496-BF89-1C110F79C25E Q45945673-00B9C32B-D906-4A47-8D0F-34DF55AC4368 Q46200749-1CA22466-5928-4B1B-911C-4F9AA09F92CC Q47583578-F7069B5B-9B13-4AED-8467-187A83BA2664 Q48155934-ACD95FD4-E02A-4AD2-9B3E-C56117E5D9A8 Q49600767-F742E56C-1401-4FAB-8E12-A6DBCC59CFBF Q52564843-096A4386-2E05-4CEB-B752-BE5C26F11ED7 Q52684163-03817D86-10AA-4470-B90A-709D38FA6DF0 Q54526379-B9CBDE01-C3B1-4BAB-9D25-621647A1D434 Q54689860-F7383B77-AE93-4F10-80E2-F84C09728E6E Q55286638-E3C014AA-45EB-4F7F-AA8B-0D33B97963D6 Q55354503-F7129BFB-2A74-4950-81AD-FAE714AA7134 Q55478606-92FEC57F-5620-4D98-A988-6BD4964E85F4

P2860

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments

http://www.wikidata.org/entity/Q27022866

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@ast

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@en

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@nl

type

label

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@ast

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@en

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@nl

prefLabel

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@ast

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@en

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@nl

P1433

Q27022866-763E1A0C-744F-4A52-A83A-28C58DB4F070

P1476

Q27022866-37B97FCD-D81B-49B2-B196-930B042E04E8

P2093

Q27022866-1CCE0024-3F6D-47FF-BA72-141E31BCE2EB

Q27022866-7F27471B-AC17-4878-BBB0-7A93F3EDB502

P2860

Q27022866-0B4E5A25-C3C3-464E-B83F-8C1EC3490A47

Q27022866-14E0CD45-44BA-4DAE-9E5E-64709A26E543

Q27022866-160DDF70-8326-4E6F-B78D-9777066B44DF

Q27022866-1A1F602E-A601-48E7-8D13-CD0B0DCBB78D

Q27022866-1F1A3F8F-4727-4F40-940A-CFE39876B2AB

Q27022866-26C53AB5-B6EF-4CA9-9CD4-59AA4424A7F3

Q27022866-28B5F326-B108-48B3-9810-83F38915248A

Q27022866-2AAD1936-E0C8-4395-819A-D7785A451FE5

Q27022866-2BFDD686-0A52-46F4-9CB8-CF6AA2F65E94

Q27022866-3862E02D-B681-45AD-A436-68DF4E067A5A

P304

Q27022866-F20C886D-CC42-4FD5-8D05-2EBB0AA1FAF8

P31

Q27022866-0E3803CE-5F75-4F89-8D92-B3BBCE136427

Q27022866-A53786BB-62F7-44DA-A221-E2ECD9CA9DD3

P3181

Q27022866-289CF622-ABAA-4608-AB29-AE61A42A9D0D

P356

Q27022866-713DF4ED-4698-4829-9EB4-4B05CA465490

P407

Q27022866-C02D732F-76F9-4CF5-BE07-04FCFB3AEC91

P433

Q27022866-2346F514-1656-4C75-8FEF-458A8B10A83B

P478

Q27022866-F93FF658-B196-44F4-9DD5-67108ACABA1A

P50

Q27022866-258806C8-8638-4417-8B17-440360B7E454

Q27022866-F01A7D3A-1734-4BB8-A961-E59C066D1194

P577

Q27022866-B70D352F-01F2-4672-B930-F3AABBD80D85

P5875

Q27022866-D00F6DF7-4830-4866-8675-6B03AF931862

P698

Q27022866-C9D21E93-D630-46D3-96B4-8FAF5002B39B

P921

Q27022866-1E5336A3-FCC4-430F-92F7-0B6BB84A6692

P3181

P356

J.1600-0625.2012.01552.X

P1433

Experimental Dermatology

P1476

Hidradenitis suppurativa: view ...... hogenesis and novel treatments

@en

P2093

Jon D Laman

http://www.w3.org/2001/XMLSchema#string

Jurr Boer

http://www.w3.org/2001/XMLSchema#string

P2860

The aryl hydrocarbon receptor: a perspective on potential roles in the immune system

The skin microbiome

Inflammation and metabolic disorders

Adipokines in inflammation and metabolic disease

Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis.

Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery.

Idiopathic granulomatous mastitis: case reports and review of literature.

Cigarette smoking as a triggering factor of hidradenitis suppurativa.

Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa.

The relative toxicity of compounds in mainstream cigarette smoke condensate.

P304

735-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2841612

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1600-0625.2012.01552.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Hessel H Van Der Zee

P577

2012-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230654060

http://www.w3.org/2001/XMLSchema#string

P698

22882284

http://www.w3.org/2001/XMLSchema#string

P921